US Stock MarketDetailed Quotes
LLY Eli Lilly and Co
- 824.260
- -8.180-0.98%
Trading Nov 12 15:15 ET
782.48BMarket Cap89.11P/E (TTM)
833.820High810.720Low2.45MVolume828.010Open832.440Pre Close2.00BTurnover0.26%Turnover Ratio142.11P/E (Static)949.32MShares972.53052wk High54.95P/B781.64BFloat Cap558.92052wk Low5.03Dividend TTM948.29MShs Float972.530Historical High0.61%Div YieldTTM2.78%Amplitude5.287Historical Low819.762Avg Price1Lot Size
About Eli Lilly and Co Company
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Company Profile
SymbolLLY
Company NameEli Lilly and Co
Listing DateApr 1, 1973
Founded1876
CEOMr. David A. Ricks
MarketNYSE
Employees43000
Fiscal Year Ends12-31
AddressLilly Corporate Center
CityIndianapolis
ProvinceIndiana
CountryUnited States of America
Zip Code46285
Phone1-317-276-2000
Websitehttp://www.lilly.com
Company Executives
- Name
- Position
- Salary
- David A. Ricks
- Chairman of the Board, President and Chief Executive Officer
- 26.57M
- Lucas Montarce
- Executive Vice President and Chief Financial Officer
- --
- Dr. Daniel M. Skovronsky, M.D.
- Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology
- 11.85M
- Diogo Rau
- Executive Vice President, Chief Information Officer and Chief Digital Officer
- --
- Alonzo Weems
- Executive Vice President, Enterprise Risk Management, Chief Ethics Officer and Compliance Officer
- --
- Donald A. Zakrowski
- Senior Vice President, Finance and Chief Accounting Officer
- --
- Eric Dozier
- Executive Vice President, Human Resources and Diversity
- --
- Anne E. White
- Executive Vice President and President, Lilly Neuroscience
- --
- Ilya Yuffa
- Executive Vice President and President, Lilly International
- --
- Patrik Jonsson
- Executive Vice President and President, Lilly Diabetes and Obesity; President, Lilly USA
- --
- Jacob S. Van Naarden
- Executive Vice President and President, Loxo
- 4.89M
- Edgardo Hernandez
- Executive Vice President and President, Manufacturing Operations
- --
- Anat Hakim
- Executive Vice President, General Counsel and Secretary
- 7.01M
- Johna L. Norton
- Executive Vice President, Global Quality
- --
- Kimberly H. Johnson
- Independent Director
- 316.00K
- Gabrielle Sulzberger, J.D.,M.B.A.
- Independent Director
- 335.50K
- Ralph Alvarez
- Independent Director
- 336.00K
- Dr. William G. Kaelin, Jr
- Independent Director
- 349.15K
- Katherine Baicker
- Independent Director
- 336.00K
- Dr. Mary Lynne Hedley,PhD
- Independent Director
- 319.00K
- Karen Walker
- Independent Director
- 359.00K
- Jamere Jackson
- Independent Director
- 345.00K
- Juan R. Luciano
- Lead Independent Director
- 373.00K
- Jon Erik Fyrwald
- Independent Director
- 344.88K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
